B細胞急性リンパ性白血病の再発/耐性成人におけるブレクスカバトゲン・オートルユケルのアウトカムに対する健康の社会的決定因子の影響
Timothy E O'Connor1, Chenyu Lin2, Gregory W Roloff3
1Loyola University Medical Center, Maywood, IL, USA.
Bone marrow transplantation
|August 23, 2025
まとめ
社会的健康決定因子 (SDoH) は,ブレクシカバトゲン・オートルキュセル (ブレクシカセル) で治療された再発性または耐性B細胞急性リンパ性白血病 (B- ALL) の成人のアウトカムに有意な影響を及ぼさなかった. 黒人人種は全生存率の低下と関連していたが,他のSDoHの要因は進行しないまたは全生存率に影響しなかった.
科学分野:
- 血液学
- 腫瘍学
- 医療サービス研究
背景:
- Brexucabtagene autoleucel (brexu- cel) は,再発した/耐性B細胞急性リンパ性白血病 (B- ALL) に対するCART細胞療法である.
- 健康の社会的決定因子 (SDoH) は,がん治療の結果に影響を与える可能性があります.
- B- ALLに対するブレクス細胞治療に対するSDoHの影響は十分に理解されていません.
研究 の 目的:
- Brexu- celで治療されたR/ R B- ALLの成人におけるSDoHとアウトカムの関連性を調査する.
- 人種,民族,またはSDoHが,無進行生存率 (PFS) と全生存率 (OS) に影響するかどうかを評価する.
主な方法:
- Brexu- celで治療されたR/ R B- ALLの189人の成人患者の遡及分析 (2021~2023年).
- コックスの比例リスクモデルでは,人種,民族,保険,CAR Tセンターからの距離,社会的な欠乏指数 (SDI) がPFSとOSに与える影響を評価した.
- 患者は人種,民族,保険の種類,SDI (高対低/中等) によって分類された.
主要な成果:
- 黒人の全生存率 (OS) は著しく低下した (HR3. 48).
- ヒスパニック系患者と非ヒスパニック系患者では,PFSやOSにおいて有意な差異は認められなかった.
- 結果 (PFSとOS) は,保険とSDIを含む他のSDoH要因から一般的に独立していた.
結論:
- R/ R B- ALLでブレクシュセルを投与された患者の全般的なSDoHは,より悪いOSとの関連を示した.
- これらの発見は,ほとんどのSDoHに関係なく,さまざまな患者集団でブレクスセルの有効性が比較可能であることを示唆しています.
- CAR T細胞治療を受けている黒人の患者の生存の格差の特定の要因を理解するためにさらなる研究が必要です.
関連する概念動画
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

